Search results

Page results

• Access to the paediatric emergency department into the new year

  Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.

• Gender Identity and Development Service (GIDS) - legal update

  The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.

• Patient Advice and Liaison Service (PALS)

  The Patient Advice and Liaison Service (PALS) provides impartial advice and assistance in answering questions and resolving concerns that patients, their relatives, friends and carers might have accessing the NHS services provided by UCLH.

• Genomics England drives sickle cell research through the diverse data initiative

  We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.

• UCLH welcomes new clinical nurse specialist appointed to support asbestos-related cancer patients

  Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area. 

• Advice for patients before they are admitted to UCLH

  We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.

• UCLH haematology team wins award

  Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.

• UCLH first in the NHS to use Nanoknife for prostate cancer

  A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.

• Vincent Wolf, patient governor

  I worked as a senior directorate accountant in finance in the NHS across a wide range of directorates, both corporate and clinical areas, working closely with these directorates on their financial plans, monitoring and forward planning.

• Hormone injections for prostate cancer patients to be given in primary care across NCL

  Men currently attending a hospital outpatient clinic for prostate hormone injections every 3 or 6 months will be advised that (unless not clinically appropriate) their next injection will be administered at a local GP practice, usually by the practice nurse.